EO-2463

N/A

Report date: 2026/01/23 16:48:57

Base Information

Drug NameEO-2463
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsLymphoma, FollicularLymphoma, B-Cell, Marginal Zone
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItalyFrance +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnterome
China Registration ClassN/A

Develop Information

Active CompaniesEnterome
Inactive CompaniesN/A
Active IndicationsLymphoma, FollicularLymphoma, B-Cell, Marginal Zone
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A